Dorff, T. B., Peer, A., Sharma, M. R., Joshua, A. M., Powderly, J. D., Shimazu, Y., Aggarwal, R. R., Carneiro, B. A., Szmulewitz, R. Z., Abraham, L., Okubo, S., Stevenson, C., Alaei, S., Wang, S., Jalaluddin, M., Ogunyankin, O., Mudd, S., Quinn, D. I., Saad, F., Tolcher, A. W. (2026). A phase 1, first-in-human (FIH) study evaluating the safety, pharmacokinetics, and efficacy of ABBV-969 in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5014